JAZZ
Price:
$166.91
Market Cap:
$10.14B
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid tumors. Its lead marketed products include Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in narcolepsy patients seven years of age and older; Sunosi for the treatment of EDS in patients with narcolepsy and obstructive sleep apnea; Erwinaze to tr...[Read more]
Industry
Biotechnology
IPO Date
2007-06-01
Stock Exchange
NASDAQ
Ticker
JAZZ
According to Jazz Pharmaceuticals plc’s latest financial reports and current stock price. The company's current PE Ratio is -27.05. This represents a change of 2.06% compared to the average of -1.25 of the last 4 quarters.
The mean historical PE Ratio of Jazz Pharmaceuticals plc over the last ten years is 9.54. The current -27.05 PE Ratio has changed -28444.21% with respect to the historical average. Over the past ten years (40 quarters), JAZZ's PE Ratio was at its highest in in the March 2022 quarter at 1.46K. The PE Ratio was at its lowest in in the March 2024 quarter at -127.25.
Average
9.54
Median
16.59
Minimum
-44.47
Maximum
38.54
Discovering the peaks and valleys of Jazz Pharmaceuticals plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 138.07%
Maximum Annual PE Ratio = 38.54
Minimum Annual Increase = -159.99%
Minimum Annual PE Ratio = -44.47
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 13.60 | -27.55% |
| 2023 | 18.77 | -142.20% |
| 2022 | -44.47 | 92.34% |
| 2021 | -23.12 | -159.99% |
| 2020 | 38.54 | 138.07% |
| 2019 | 16.19 | -2.66% |
| 2018 | 16.63 | 0.38% |
| 2017 | 16.57 | -0.34% |
| 2016 | 16.62 | -36.36% |
| 2015 | 26.12 | -84.41% |
The current PE Ratio of Jazz Pharmaceuticals plc (JAZZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-4.03
5-year avg
0.66
10-year avg
9.54
Jazz Pharmaceuticals plc’s PE Ratio is less than Avidity Biosciences, Inc. (-20.35), greater than Caris Life Sciences, Inc. (-36.95), less than Merus N.V. (-20.81), greater than Madrigal Pharmaceuticals, Inc. (-46.18), greater than Abivax S.A. (-30.21), less than Cytokinetics, Incorporated (-10.62), less than Halozyme Therapeutics, Inc. (12.39), greater than Rhythm Pharmaceuticals, Inc. (-35.36), less than Nuvalent, Inc. (-20.21), greater than Axsome Therapeutics, Inc. (-32.26),
| Company | PE Ratio | Market cap |
|---|---|---|
| -20.35 | $9.39B | |
| -36.95 | $7.99B | |
| -20.81 | $7.30B | |
| -46.18 | $13.00B | |
| -30.21 | $8.36B | |
| -10.62 | $7.92B | |
| 12.39 | $7.40B | |
| -35.36 | $7.05B | |
| -20.21 | $7.77B | |
| -32.26 | $7.46B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jazz Pharmaceuticals plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Jazz Pharmaceuticals plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Jazz Pharmaceuticals plc's PE Ratio?
How is the PE Ratio calculated for Jazz Pharmaceuticals plc (JAZZ)?
What is the highest PE Ratio for Jazz Pharmaceuticals plc (JAZZ)?
What is the 3-year average PE Ratio for Jazz Pharmaceuticals plc (JAZZ)?
What is the 5-year average PE Ratio for Jazz Pharmaceuticals plc (JAZZ)?
How does the current PE Ratio for Jazz Pharmaceuticals plc (JAZZ) compare to its historical average?